Literature DB >> 6704283

Dietary influences on the kinetics of antipyrine and aminopyrine in human subjects.

K Krishnaswamy, R Kalamegham, N A Naidu.   

Abstract

The possible dietary influences on in vivo antipyrine and aminopyrine kinetics with reference to energy (1500, 1800, 3000 kcal) and protein (5, 10, 15, 20% protein energy-PE) intake were studied in a carefully controlled metabolic experiment in young healthy adult male volunteers aged between 25-34 years. Antipyrine and aminopyrine were used to evaluate drug metabolism. On 1500 kcal intake with 10% PE, the metabolism of both aminopyrine and antipyrine were significantly reduced whereas on 1800 kcal with 10% PE intake, only aminopyrine metabolism decreased significantly as compared to 3000 kcal with 10% PE. Antipyrine clearance on 1800 kcal with 10% PE however had not decreased to the same extent as on 1500 kcal with 10% PE. The results indicate that on low calorie intake with 10% PE, the drug metabolism is decreased. When the protein intake on 1500 kcal was doubled (20% PE) there was a significant stimulation of both aminopyrine and antipyrine metabolism. Aminopyrine and antipyrine clearances on 3000 kcal with 5% PE were significantly reduced as compared to 3000 kcal with 10% and 15% PE indicating that unlike proteins, carbohydrate and/or fat calories per se do not significantly stimulate drug metabolism. When the protein energy in the diet was increased from 5% to 10% or 15% at 3000 kcal, there was a stimulation of both antipyrine and aminopyrine metabolism. Significant differences between 10% and 15% of protein energy were not observed when the energy was adequate (3000 kcal). Therefore it is necessary to consider both proteins and energy as important variables affecting drug clearances from plasma in malnourished conditions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6704283      PMCID: PMC1463327          DOI: 10.1111/j.1365-2125.1984.tb02328.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  24 in total

1.  Unaltered metabolism of antipyrine and tolbutamide in fasting man.

Authors:  M M Reidenberg; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1975-06       Impact factor: 6.875

2.  Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.

Authors:  E S Vesell; G T Passananti; P A Glenwright; B H Dvorchik
Journal:  Clin Pharmacol Ther       Date:  1975-09       Impact factor: 6.875

3.  Interactions between nutritional factors and drug biotransformations in man.

Authors:  A P Alvares; K E Anderson; A H Conney; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

Review 4.  Genetic and environmental factors affecting drug disposition in man.

Authors:  E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

Review 5.  Nutrition and drug-metabolizing enzymes.

Authors:  T C Campbell
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

6.  Effect of phenobarbital treatment on the activities of NADPH-dependent enzymes of liver microsomes in fasting or sucrose-fed rats.

Authors:  R Kato
Journal:  Jpn J Pharmacol       Date:  1967-06

7.  Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef.

Authors:  A H Conney; E J Pantuck; K C Hsiao; W A Garland; K E Anderson; A P Alvares; A Kappas
Journal:  Clin Pharmacol Ther       Date:  1976-12       Impact factor: 6.875

8.  Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man.

Authors:  A Kappas; K E Anderson; A H Conney; A P Alvares
Journal:  Clin Pharmacol Ther       Date:  1976-12       Impact factor: 6.875

9.  Influence of varying energy intake on nitrogen balance in men on two levels of protein intake.

Authors:  C N Rao; A N Naidu; B S Rao
Journal:  Am J Clin Nutr       Date:  1975-10       Impact factor: 7.045

10.  Microsomal enzymes in malnutrition as determined by plasma half life of antipyrine.

Authors:  K Krishnaswamy; A N Naidu
Journal:  Br Med J       Date:  1977-02-26
View more
  11 in total

Review 1.  Dietary effects on drug metabolism and transport.

Authors:  Robert Z Harris; Graham R Jang; Shirley Tsunoda
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  The effect of dietary energy and protein deficiency on drug metabolism.

Authors:  O Hamberg; L Ovesen; A Dorfeldt; S Loft; J Sonne
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  The effect of a diet rich in brussels sprouts on warfarin pharmacokinetics.

Authors:  L Ovesen; S Lyduch; M L Idorn
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Inter-subject and ethnic differences in paracetamol metabolism.

Authors:  J A Critchley; G R Nimmo; C A Gregson; N M Woolhouse; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

Review 5.  The influence of nutrition on the systemic availability of drugs. Part II: Drug metabolism and renal excretion.

Authors:  I Walter-Sack
Journal:  Klin Wochenschr       Date:  1987-11-02

Review 6.  Age-related changes in the gastrointestinal system. Effects on drug therapy.

Authors:  F L Iber; P A Murphy; E S Connor
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

Review 7.  Influence of diet and nutritional status on drug metabolism.

Authors:  I Walter-Sack; U Klotz
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

Review 8.  Influences of diet and nutrition on clinical pharmacokinetics.

Authors:  K E Anderson
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

Review 9.  Drug metabolism and pharmacokinetics in malnourished children.

Authors:  K Krishnaswamy
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

10.  Effect of Food on the Steady-State Pharmacokinetics of Delavirdine in Patients with HIV Infection.

Authors:  Gene D Morse; Margaret A Fischl; Mark J Shelton; Steve R Cox; Leslie Thompson; Andrew A Della-Coletta; William W Freimuth
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.